Previous Blogs

Avatar

By Lloyd Waxman and Vinod Vilivalam

June 18, 2014

The use of proteins as therapeutics has focused attention on the need to maintain the stability of these labile molecules during both storage and shipment. The trend in the pharmaceutical industry has been to package therapeutic proteins in prefillable syringes made of glass. However, some biologics are not stable in glass syringes due to sensitivity to adhesives used in their manufacture and to tungsten oxides generated during needle placement.

Avatar

By Global Communications

June 12, 2014

In recent seminars in Hyderabad and Ahmedabad, India, West’s Tibor Hlobik discussed the challenges faced by injectable drug manufacturers to minimize risk, accelerate product development, ensure patient safety and improve ease of administration. Similar seminars were held in China and Korea.

Avatar

By Tibor Hlobik

March 05, 2014

Many of the top-selling biologic drug products will soon come off-patent. As a result, according to IMS, the biosimilar market is expected to reach between US$1.9-2.6 billion by 2015.